The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole
Open accessAbstract
OBJECTIVE: To compare topical natamycin vs voriconazole in the treatment of filamentous fungal keratitis. METHODS: This phase 3, double-masked, multicenter trial was designed to randomize 368 patients to voriconazole (1%) or natamycin (5%), applied topically every hour while awake until reepithelialization, then 4 times daily for at least 3 weeks. Eligibility included smear-positive filamentous fungal ulcer and visual acuity of 20/40 to 20/400. MAIN OUTCOME MEASURES: The primary outcome was best spectacle-corrected visual acuity at 3 months; secondary outcomes included corneal perforation and/or therapeutic penetrating keratoplasty. RESULTS: A total of 940 patients were screened and 323 were enrolled. Causative organisms included Fusarium (128 patients [40%]), Aspergillus (54 patients [17%]), and other filamentous fungi (141 patients [43%]). Natamycintreated cases had significantly better 3-month best spectacle-corrected visual acuity than voriconazole-treated cases (regression coefficient=0.18 logMAR; 95% CI, 0.30 to 0.05; P=.006). Natamycin-treated cases were less likely to have perforation or require therapeutic penetrating keratoplasty (odds ratio=0.42; 95% CI, 0.22 to 0.80; P=.009). Fusarium cases fared better with natamycin than with voriconazole (regression coefficient=0.41 logMAR; 95% CI,0.61 to 0.20; P<.001; odds ratio for perforation=0.06; 95% CI, 0.01 to 0.28; P<.001), while non-Fusarium cases fared similarly (regression coefficient=0.02 logMAR; 95% CI, 0.17 to 0.13; P=.81; odds ratio for perforation=1.08; 95% CI, 0.48 to 2.43; P=.86). CONCLUSIONS: Natamycin treatment was associated with significantly better clinical and microbiological outcomes than voriconazole treatment for smear-positive filamentous fungal keratitis, with much of the difference attributable to improved results in Fusarium cases. APPLICATION TO CLINICAL PRACTICE: Voriconazole should not be used as monotherapy in filamentous keratitis. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00996736
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corneal blindness: a global perspective.
Whitcher, J. P., Srinivasan, M., & Upadhyay, M. P. (2001) · Europe PMC (PubMed Central) · Cited by 1,563
Self-citationEpidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India
Srinivasan, M., Gonzales, C. A., George, C., Cevallos, V., Mascarenhas, J. M., Asokan, B., Wilkins, J., Smolin, G., & Whitcher, J. P. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.11.965 · Cited by 661
Self-citationMultistate Outbreak of Fusarium Keratitis Associated With Use of a Contact Lens Solution
Chang, D. C., Grant, G. B., O’Donnell, K., Wannemuehler, K. A., Noble-Wang, J., Rao, C. Y., Jacobson, L. M., Crowell, C. S., Sneed, R. S., Lewis, F. M. T., et al. (2006) · JAMA · doi:10.1001/jama.296.8.953 · Cited by 600
The Age-Related Eye Disease Study (AREDS)
(1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00031-8 · Cited by 585
Microbial Keratitis in South India: Influence of Risk Factors, Climate, and Geographical Variation
Bharathi, M. J., Ramakrishnan, R., Meenakshi, R., Padmavathy, S., Shivakumar, C., & Srinivasan, M. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580601001347 · Cited by 332
Self-citationWilhelmus, K. R., Gee, L., Hauck, W. W., Kurinij, N., Dawson, C. R., Jones, D. B., Barron, B. A., Kaufman, H. E., Sugar, J., Hyndiuk, R. A., et al. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31087-6 · Cited by 259
An Outbreak of Fusarium Keratitis Associated With Contact Lens Wear in Singapore
Khor, W.-B., Aung, T., Saw, S.-M., Wong, T.-Y., Tambyah, P. A., Tan, A.-L., Beuerman, R., Lim, L., Chan, W.-K., Heng, W.-J., et al. (2006) · JAMA · doi:10.1001/jama.295.24.2867 · Cited by 255
Comparison of Natamycin and Voriconazole for the Treatment of Fungal Keratitis
Prajna, N. V. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.102 · Cited by 183
Self-citationLalitha, P. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.6.789 · Cited by 173
Trends in Fungal Keratitis in the United States, 2001 to 2007
Gower, E. W., Keay, L. J., Oechsler, R. A., Iovieno, A., Alfonso, E. C., Jones, D. B., Colby, K., Tuli, S. S., Patel, S. R., Lee, S. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.048 · Cited by 169
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Update on the Management of Infectious Keratitis
Austin, A., Lietman, T., & Rose-Nussbaumer, J. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.012 · Cited by 613
Self-citationFungal keratitis: An overview of clinical and laboratory aspects
Mahmoudi, S., Masoomi, A., Ahmadikia, K., Tabatabaei, S. A., Soleimani, M., Rezaie, S., Ghahvechian, H., & Banafsheafshan, A. (2018) · Mycoses · doi:10.1111/myc.12822 · Cited by 260
Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline?
Al-Hatmi, A., de Hoog, G. S., & Meis, J. F. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s180912 · Cited by 47
“of 1% voriconazole compared to 5% natamycin alone in eye drops.(77) Rees et al evaluated in vitro activities of natamycin”
Method
Metadata
- Authors
- Prajna, N. V., Krishnan, T., Mascarenhas, J., Rajaraman, R., Prajna, L., Srinivasan, M., Raghavan, A., Oldenburg, C. E., Ray, K. J., Zegans, M. E., McLeod, S. D., Porco, T. C., Acharya, N. R., Lietman, T. M., & Mycotic Ulcer Treatment Trial Group, F. T.
- Venue
- JAMA Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-04-01
- Volume
- 131
- Issue
- 4
- Pages
- 422
- ISSN
- 2168-6165 (ISSN-L)
- OpenAlex
- W2001276323
- Cited by
- 348
- References
- 14
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole. https://app.cochat.ai/papers/10.1001/jamaophthalmol.2013.1497
- The paper
- Prajna, N. V., Krishnan, T., Mascarenhas, J., Rajaraman, R., Prajna, L., Srinivasan, M., Raghavan, A., Oldenburg, C. E., Ray, K. J., Zegans, M. E., McLeod, S. D., Porco, T. C., Acharya, N. R., Lietman, T. M., & Mycotic Ulcer Treatment Trial Group, F. T. (2013). The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole. JAMA Ophthalmology. https://doi.org/10.1001/jamaophthalmol.2013.1497
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.